April 1, 2024Open Access

Clinical Outcomes and Safety of Upper Endoscopy While on Glucagon-Like Peptide-1 Receptor Agonists

Key Points

Key points are not available for this paper at this time.

Abstract

Glucose-like peptide-1-receptor agonists (GLP-1RAs) have become integral to the management of type 2 diabetes and obesity. GLP-1RAs work in part through delaying gastric emptying, raising concerns about retained gastric contents (RGC) during esophagogastroduodenoscopy (EGD).

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Firkins et al. (Mon,) studied this question.

www.synapsesocial.com/papers/68e70d94b6db6435876870fa — DOI: https://doi.org/10.1016/j.cgh.2024.03.013

Authors

Stephen A. Firkins

J. C. Yates

Neehal Shukla

Journals

Clinical Gastroenterology and Hepatology

Actions

Institutions

Cleveland Clinic

Community Care

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Clinical Outcomes and Safety of Upper Endoscopy While on Glucagon-Like Peptide-1 Receptor Agonists

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Cite this study

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion